We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+31.97%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.12B
AUM Growth
-$319M
Cap. Flow
-$563M
Cap. Flow %
-50.08%
Top 10 Hldgs %
21.26%
Holding
360
New
82
Increased
64
Reduced
136
Closed
54

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$15.3M
2
BR icon
Broadridge
BR
+$13.9M
3
PARA
Paramount Global Class B
PARA
+$11.1M
4
D icon
Dominion Energy
D
+$10.6M
5
NEE icon
NextEra Energy
NEE
+$9.11M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.12%
2 Technology 14.48%
3 Financials 14%
4 Industrials 10.81%
5 Healthcare 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TER icon
201
Teradyne
TER
$54.8B
$742K 0.07%
8,778
+4,324
+97% +$290K
SPLK
202
DELISTED
Splunk Inc
SPLK
$738K 0.07%
3,712
+947
+34% +$150K
CPRI icon
203
Capri Holdings
CPRI
$1.77B
$715K 0.06%
+45,750
New +$677K
AZO icon
204
AutoZone
AZO
$48.3B
$710K 0.06%
+629
New +$663K
USFD icon
205
US Foods
USFD
$21.4B
$708K 0.06%
35,905
+12,735
+55% +$244K
MYOK
206
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$706K 0.06%
7,303
-2,137
-23% -$178K
HASI icon
207
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
$705K 0.06%
24,763
+3,621
+17% +$98.9K
CSD icon
208
Invesco S&P Spin-Off ETF
CSD
$225M
$695K 0.06%
18,443
WHF icon
209
WhiteHorse Finance
WHF
$141M
$690K 0.06%
66,977
-1,218
-2% -$11.3K
PEP icon
210
PepsiCo
PEP
$186B
$689K 0.06%
5,213
+922
+21% +$122K
RARE icon
211
Ultragenyx Pharmaceutical
RARE
$2.65B
$687K 0.06%
+8,779
New +$581K
WOLF icon
212
Wolfspeed
WOLF
$1.2B
$685K 0.06%
+11,581
New +$558K
GH icon
213
Guardant Health
GH
$19.5B
$683K 0.06%
8,423
+2,038
+32% +$164K
FCN icon
214
FTI Consulting
FCN
$4.82B
$682K 0.06%
5,954
-1,672
-22% -$202K
COHR icon
215
Coherent
COHR
$55.2B
$676K 0.06%
+14,308
New +$567K
FDUS icon
216
Fidus Investment
FDUS
$737M
$673K 0.06%
74,157
+782
+1% +$6.79K
IGIB icon
217
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.3B
$668K 0.06%
+11,070
New +$645K
QLYS icon
218
Qualys
QLYS
$4.84B
$666K 0.06%
+6,399
New +$670K
QTRX icon
219
Quanterix
QTRX
$173M
$660K 0.06%
24,079
+4,460
+23% +$113K
BKI
220
DELISTED
Black Knight, Inc. Common Stock
BKI
$660K 0.06%
9,090
CIEN icon
221
Ciena
CIEN
$55.3B
$654K 0.06%
+12,072
New +$600K
DLN icon
222
WisdomTree US LargeCap Dividend Fund
DLN
$6.24B
$654K 0.06%
14,080
RNG icon
223
RingCentral
RNG
$4.05B
$651K 0.06%
2,285
-473
-17% -$120K
MTN icon
224
Vail Resorts
MTN
$5.19B
$638K 0.06%
3,505
EQC.PRD
225
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
$629K 0.06%
23,000

Similar funds

Advisory Research's Q2 2020 Portfolio in Review

As of Q2 2020, Advisory Research held 360 positions worth $1.12B, down 22% from $1.44B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Advisory Research withdrew a net $563M in Q2 2020, closing 54 positions and reducing 136 holdings. Its most notable exit was Chunghwa Telecom, an estimated $18.4M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

Against the trend, Advisory Research opened a new position in AbbVie worth $17M.

  • Advisory Research's largest Q2 2020 buy was AbbVie: 173,370 shares worth $17M.
  • Advisory Research added most to Motorola Solutions in Q2 2020, an estimated $5.55M increase.
  • Advisory Research's biggest Q2 2020 reduction was Core Mark Holding Co., Inc., cutting an estimated $34M.
  • Advisory Research fully exited Chunghwa Telecom in Q2 2020, selling an estimated $18.4M.
  • Advisory Research's ten largest holdings make up 21% of its $1.12B portfolio in Q2 2020.
  • Advisory Research opened 82 new positions and closed 54 in Q2 2020.
  • Advisory Research's portfolio value fell 22% quarter-over-quarter to $1.12B.

Based on Advisory Research's 13F filing for Q2 2020, filed 13 Aug 2020.